A life settlement firm says institutional investors ought to think about investing in the secondary life market.
The amount of face value traded doubled to $12 billion last year, and investors should be attracted by the lack of correlation between the performance of life settlement portfolios and the performance of the stock market, according to William Scott Page of Wm. Page & Associates Inc., Atlanta, the parent of The Lifeline Program life settlement operation.